FDA issued a Warning Letter to Hybrid Pharma, LLC on 11/30/2018 as a result of this inspection.
483 Hybrid Pharma Jul 2016

483 Hybrid Pharma Jul 2016

Stephanie Crockett FDA, Latorie Jones FDA$119.00 - Available Now

FDA investigators audited the Hybrid Pharma - Deerfield Beach, FL, United States facility and issued 9 inspectional observations (via FDA 483) on 28 Jul 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 9
  • Inspection end: 28 Jul 2016
  • Location: Deerfield Beach, United States
  • FEI: 3011319445
Add To Cart